Atlas Trials

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

Clinical trial NCT00037206 · COMPLETED

Trial details

NCT number
NCT00037206
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Aspergillosis
Start date
2002-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.